pioglitazone has been researched along with Equine Diseases in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wearn, JG | 1 |
| Suagee, JK | 1 |
| Crisman, MV | 1 |
| Corl, BA | 1 |
| Hulver, MW | 1 |
| Hodgson, DR | 1 |
| Geor, RJ | 1 |
| McCutcheon, LJ | 1 |
1 other study available for pioglitazone and Equine Diseases
| Article | Year |
|---|---|
Effects of the insulin sensitizing drug, pioglitazone, and lipopolysaccharide administration on markers of systemic inflammation and clinical parameters in horses.
Topics: Adipose Tissue; Animals; Biomarkers; Chemokine CCL2; Chemokine CCL8; Female; Horse Diseases; Horses; | 2012 |